OSE Immunotherapeutics

OSE Immunotherapeutics is a biotechnology company led by world-class immunologists, directly or through collaborations, developing innovative immunotherapies for immune activation and regulation in immuno-oncology and autoimmune diseases. The company's R&D in immunology is based on three platforms: T-cell-based vaccines, immuno-oncology (myeloid targets), and autoimmunity and inflammation.